Description and Brand Names
Drug information provided by: Micromedex
US Brand Name
Ibrutinib is used to treat mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) in patients who have received at least one previous treatment with another medicine. This medicine is also used to treat patients with CLL who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. This medicine is also used to treat Waldenström’s macroglobulinemia (WM). Ibrutinib interferes with the growth of cancer cells, which are eventually destroyed by the body. It is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: